Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 257

1.

Diagnosis and management of Silver-Russell syndrome: first international consensus statement.

Wakeling EL, Brioude F, Lokulo-Sodipe O, O'Connell SM, Salem J, Bliek J, Canton AP, Chrzanowska KH, Davies JH, Dias RP, Dubern B, Elbracht M, Giabicani E, Grimberg A, Grønskov K, Hokken-Koelega AC, Jorge AA, Kagami M, Linglart A, Maghnie M, Mohnike K, Monk D, Moore GE, Murray PG, Ogata T, Petit IO, Russo S, Said E, Toumba M, Tümer Z, Binder G, Eggermann T, Harbison MD, Temple IK, Mackay DJ, Netchine I.

Nat Rev Endocrinol. 2016 Sep 2. doi: 10.1038/nrendo.2016.138. [Epub ahead of print]

PMID:
27585961
2.

Beneficial effects of growth hormone in young adults with Prader-Willi syndrome: a 2-year cross-over trial.

Kuppens RJ, Bakker NE, Siemensma EP, Tummers-de Lind van Wijngaarden RF, Donze SH, Festen DA, van Alfen-van der Velden JA, Stijnen T, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2016 Aug 23:jc20162594. [Epub ahead of print]

PMID:
27552545
3.

Long-term metabolic risk among children born premature or small for gestational age.

Mericq V, Martinez-Aguayo A, Uauy R, Iñiguez G, Van der Steen M, Hokken-Koelega A.

Nat Rev Endocrinol. 2016 Aug 19. doi: 10.1038/nrendo.2016.127. [Epub ahead of print] Review.

PMID:
27539244
4.

Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial.

Kuppens RJ, Donze SH, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2016 Aug 3. doi: 10.1111/cen.13169. [Epub ahead of print]

PMID:
27486141
5.

Growth and Metabolism in Children Born Small for Gestational Age.

van der Steen M, Hokken-Koelega AC.

Endocrinol Metab Clin North Am. 2016 Jun;45(2):283-94. doi: 10.1016/j.ecl.2016.01.008. Review.

PMID:
27241965
6.

Appetite-regulating hormones in early life and relationships with type of feeding and body composition in healthy term infants.

Breij LM, Mulder MT, van Vark-van der Zee LC, Hokken-Koelega AC.

Eur J Nutr. 2016 May 11. [Epub ahead of print]

PMID:
27170102
7.

High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome.

Beauloye V, Diene G, Kuppens R, Zech F, Winandy C, Molinas C, Faye S, Kieffer I, Beckers D, Nergårdh R, Hauffa B, Derycke C, Delhanty P, Hokken-Koelega A, Tauber M.

Orphanet J Rare Dis. 2016 May 4;11(1):56. doi: 10.1186/s13023-016-0440-0.

8.

The Authors' Reply: Acylated and unacylated ghrelin during OGTT in Prader-Willi syndrome, a rebuttal to the conclusions by Kuppens et al.

Kuppens RJ, Delhanty PJ, Huisman TM, van der Lely AJ, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2016 Aug;85(2):323-4. doi: 10.1111/cen.13091. Epub 2016 May 19. No abstract available.

PMID:
27144882
9.

Longitudinal fat mass and visceral fat during the first 6 months after birth in healthy infants: support for a critical window for adiposity in early life.

Breij LM, Kerkhof GF, De Lucia Rolfe E, Ong KK, Abrahamse-Berkeveld M, Acton D, Hokken-Koelega AC.

Pediatr Obes. 2016 Apr 13. doi: 10.1111/ijpo.12139. [Epub ahead of print]

PMID:
27072083
10.

Long-Term Results of GH Treatment in Silver-Russell Syndrome (SRS): Do They Benefit the Same as Non-SRS Short-SGA?

Smeets CC, Zandwijken GR, Renes JS, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2016 May;101(5):2105-12. doi: 10.1210/jc.2015-4273. Epub 2016 Mar 23.

PMID:
27007691
11.

Acylated and unacylated ghrelin during OGTT in Prader-Willi syndrome: support for normal response to food intake.

Kuppens RJ, Delhanty PJ, Huisman TM, van der Lely AJ, Hokken-Koelega AC.

Clin Endocrinol (Oxf). 2016 Sep;85(3):488-94. doi: 10.1111/cen.13036. Epub 2016 Feb 23.

PMID:
26850227
12.

Insulin Sensitivity and β-Cell Function in SGA Children Treated With GH and GnRHa: Results of a Long-Term Trial.

van der Steen M, Lem AJ, van der Kaay DC, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2016 Feb;101(2):705-13. doi: 10.1210/jc.2015-3435. Epub 2015 Dec 14.

PMID:
26653111
13.

Leukocyte Telomere Length in Young Adults Born Preterm: Support for Accelerated Biological Ageing.

Smeets CC, Codd V, Samani NJ, Hokken-Koelega AC.

PLoS One. 2015 Nov 30;10(11):e0143951. doi: 10.1371/journal.pone.0143951. eCollection 2015.

14.

GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.

Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P, Butler G, Chihara K, Christiansen J, Cianfarani S, Clayton P, Clemmons D, Cohen P, Darendeliler F, Deal C, Dunger D, Erfurth EM, Fuqua JS, Grimberg A, Haymond M, Higham C, Ho K, Hoffman AR, Hokken-Koelega A, Johannsson G, Juul A, Kopchick J, Lee P, Pollak M, Radovick S, Robison L, Rosenfeld R, Ross RJ, Savendahl L, Saenger P, Toft Sorensen H, Stochholm K, Strasburger C, Swerdlow A, Thorner M.

Eur J Endocrinol. 2016 Feb;174(2):P1-9. doi: 10.1530/EJE-15-0873. Epub 2015 Nov 12.

15.

Maternal and Fetal Determinants of Neonatal Body Composition.

Breij LM, Steegers-Theunissen RP, Briceno D, Hokken-Koelega AC.

Horm Res Paediatr. 2015;84(6):388-95. doi: 10.1159/000441298. Epub 2015 Oct 23.

PMID:
26492188
16.

Beneficial Effect of Growth Hormone Treatment on Health-Related Quality of Life in Children with Prader-Willi Syndrome: A Randomized Controlled Trial and Longitudinal Study.

Bakker NE, Siemensma EP, van Rijn M, Festen DA, Hokken-Koelega AC.

Horm Res Paediatr. 2015;84(4):231-9. doi: 10.1159/000437141. Epub 2015 Aug 13.

PMID:
26279206
17.

Risk for Nonalcoholic Fatty Liver Disease in Young Adults Born Preterm.

Breij LM, Kerkhof GF, Hokken-Koelega AC.

Horm Res Paediatr. 2015;84(3):199-205. doi: 10.1159/000437054. Epub 2015 Aug 1.

18.

Metabolic Health in Short Children Born Small for Gestational Age Treated With Growth Hormone and Gonadotropin-Releasing Hormone Analog: Results of a Randomized, Dose-Response Trial.

van der Steen M, Lem AJ, van der Kaay DC, Bakker-van Waarde WM, van der Hulst FJ, Neijens FS, Noordam C, Odink RJ, Oostdijk W, Schroor EJ, Westerlaken C, Hokken-Koelega AC.

J Clin Endocrinol Metab. 2015 Oct;100(10):3725-34. doi: 10.1210/jc.2015-2619. Epub 2015 Aug 10.

PMID:
26259134
19.

Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone.

Swerdlow AJ, Cooke R, Albertsson-Wikland K, Borgström B, Butler G, Cianfarani S, Clayton P, Coste J, Deodati A, Ecosse E, Gausche R, Giacomozzi C, Kiess W, Hokken-Koelega AC, Kuehni CE, Landier F, Maes M, Mullis PE, Pfaffle R, Sävendahl L, Sommer G, Thomas M, Tollerfield S, Zandwijken GR, Carel JC.

Horm Res Paediatr. 2015;84(3):172-83. doi: 10.1159/000435856. Epub 2015 Jul 23.

20.

Beneficial Effects of Long-Term Growth Hormone Treatment on Adaptive Functioning in Infants With Prader-Willi Syndrome.

Lo ST, Festen DA, Tummers-de Lind van Wijngaarden RF, Collin PJ, Hokken-Koelega AC.

Am J Intellect Dev Disabil. 2015 Jul;120(4):315-27. doi: 10.1352/1944-7558-120.4.315.

PMID:
26161469
Items per page

Supplemental Content

Loading ...
Write to the Help Desk